Insights into clear cell renal cell carcinoma microenvironment: LOXL2 expression and topographical layout of CD3+ T lymphocytes
INTRODUCTION: Lysyl oxidase-like 2 (LOXL2) is involved in extracellular matrix remodeling and has been implicated in renal cancer progression. However, its relationship with clinicopathological characteristics and the topographical layout of CD3+ T lymphocytes in clear cell renal cell carcinoma (ccRCC) remains incompletely understood. MATERIAL AND METHODS: This retrospective study included 113 consecutive surgically resected ccRCCs. Tumoral LOXL2 expression was assessed immunohistochemically using a semiquantitative scoring system, considering the proportion of positive tumor cells, staining intensity, and low/high expression categories. CD3+ T cell infiltration was evaluated separately in intratumoral and peritumoral compartments, and a compartmental difference was calculated. Associations with clinicopathological characteristics and CD3+ infiltration were investigated using appropriate statistical analyses. RESULTS: Low LOXL2 expression was identified in 79 tumors (69.9%) and high expression in 34 (30.1%). CD3+ infiltration showed an overall peritumoral predominance (p = 0.002). No significant differences in CD3+ infiltration were identified between LOXL2-LOW and LOXL2-HIGH tumors. However, LOXL2 staining intensity was positively correlated with peritumoral CD3+ infiltration (ρ = 0.328, p < 0.001) and negatively correlated with the intratumoral-peritumoral CD3+ difference (ρ = -0.396, p < 0.001). Both associations remained significant after correction for multiple comparisons. In contrast, the proportion of LOXL2-positive tumor cells showed no significant correlations with CD3+ infiltration. CONCLUSIONS: LOXL2 staining intensity was associated with variations in the topographical organization of CD3+ T lymphocyte infiltration in ccRCC, particularly within the peritumoral compartment. These findings suggest a relationship between LOXL2 immunoreactivity and the organization of the tumor immune microenvironment, supporting further investigation of extracellular matrix-associated mechanisms in ccRCC.
Authors
- Andreea Rusu (ORCID: https://orcid.org/0000-0002-0752-8225)
- Irina-Draga Caruntu
- Constantin Aleodor Costin (ORCID: https://orcid.org/0009-0003-4356-4957)
- Bogdan Toma (ORCID: https://orcid.org/0000-0003-4535-6302)
- Mariana Bianca Chifu
- Andrei Daniel Timofte (ORCID: https://orcid.org/0000-0001-7905-9221)
- Simona Giusca
- Ana-Maria Gradinaru
Institutions
- Grigore T. Popa University of Medicine and Pharmacy (RO)
- Spitalul Clinic Dr. C. I. Parhon (RO)
Publication Details
- Journal
- Folia Histochemica et Cytobiologica
- Published
- 2026-11-13
- DOI
- https://doi.org/10.5603/fhc.115576
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00